Opko Health OPK
NASDAQ OPK
$1.74 +0.04 (+2.66%)
As of: Sep 22, 2026 · 10:06 AM EDT

Opko Health (OPK) Non Operating Income (2012 - 2026)

Opko Health's (OPK) quarterly Non Operating Income came in at -$6.4 million in Q2 2026, up 93.73% on a YoY basis from -$3.3 million in Q2 2025, and up 35.34% quarter-over-quarter from -$9.9 million in Q1 2026.

Analysis

Opko Health (OPK) Non Operating Income (2012 - 2026) Analysis & Trends

Opko Health (OPK) has reported Non Operating Income for 15 consecutive years, with -$6.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Income rose 93.73% year-over-year to -$6.4 million; the trailing twelve-month figure through Jun 2026 stood at -$31.6 million (down 298.32% YoY), and the FY2025 full-year result was -$124.0 million, down 187.48% from the prior year.
  • Non Operating Income climbed to -$6.4 million in Q2 2026 per OPK's latest filing, from -$9.9 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $73.6 million in Q3 2024 and bottomed at -$102.5 million in Q2 2025.
  • Historically, Non Operating Income has averaged -$12.9 million across 5 years, with a median of -$8.6 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income slumped 1619.68% in 2022, then soared 626.66% in 2024.
  • Over 5 years, Non Operating Income stood at -$46.9 million in 2022, then soared by 92.65% to -$3.4 million in 2023, then jumped by 2233.99% to $73.6 million in 2024, then tumbled by 111.67% to -$8.6 million in 2025, then increased by 25.13% to -$6.4 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$6.4 million, -$9.9 million, and -$8.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -139.24 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -6.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.43 Mn
Mar 31, 2026 -9.94 Mn
Dec 31, 2025 -8.58 Mn
Sep 30, 2025 -6.63 Mn
Jun 30, 2025 -102.54 Mn
Mar 31, 2025 -6.21 Mn
Sep 30, 2024 73.58 Mn
Jun 30, 2024 51.09 Mn
Mar 31, 2024 -11.71 Mn
Dec 31, 2023 -3.45 Mn
Sep 30, 2023 -13.97 Mn
Jun 30, 2023 -23.48 Mn
Mar 31, 2023 13.60 Mn
Dec 31, 2022 -46.91 Mn
Sep 30, 2022 -38.56 Mn
Jun 30, 2022 -75.57 Mn
Mar 31, 2022 -4.23 Mn
Dec 31, 2021 -2.73 Mn
Sep 30, 2021 -6.35 Mn
Jun 30, 2021 -16.94 Mn
API Access

Opko Health Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=OPK&period=max&api_key=YOUR_API_KEY